Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis

Autor Anti, M, Armuzzi, A, Gasbarrini, A, Gasbarrini, G
Vydáno 1998

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis

Autor Pugliese D, Felice C, Landi R, Papa A, Guidi L, Armuzzi A
Vydáno 2016-02-01

Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations

Autor Papa, A, Danese, S, Armuzzi, A, Gaetani, E, Flex, A, Pola, P, Gasbarrini, A
Vydáno 2003

The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review

Autor Volpato, E., Bosio, C., Previtali, E., Leone, S., Armuzzi, A., Pagnini, F., Graffigna, G.
Vydáno v BMC Gastroenterol (2021)

Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31

Autor Armuzzi, A, Ahmad, T, Ling, K, de Silva, A, Cullen, S, van Heel, D, Orchard, T, Welsh, K, Marshall, S, Jewell, D
Vydáno 2003

Extradigestive manifestations of Helicobacter pylori gastric infection

Autor Gasbarrini, A, Franceschi, F, Armuzzi, A, Ojetti, V, Candelli, M, Torre, E, De Lorenzo, A, Anti, M, Pretolani, S, Gasbarrini, G
Vydáno 1999

Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients

Autor Felice, C., Lewis, A., Iqbal, S., Gordon, H., Rigoni, A., Colombo, M.P., Armuzzi, A., Feakins, R., Lindsay, J.O., Silver, A.
Vydáno v Cell Mol Gastroenterol Hepatol (2020)

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report

Autor Caruso, C., Colantuono, S., Pugliese, D., Di Mario, C., Tolusso, B., Gremese, E., Papparella, G., Castrì, F., Gasbarrini, A., Romano, A., Armuzzi, A.
Vydáno v Allergy Asthma Clin Immunol (2020)

Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas

Autor Anti, M, Armuzzi, A, Morini, S, Iascone, E, Pignataro, G, Coco, C, Lorenzetti, R, Paolucci, M, Covino, M, Gasbarrini, A, Vecchio, F., Gasbarrini, G
Vydáno 2001

Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31

Autor Armuzzi, A, Ahmad, T, Ling, K-L, de Silva, A, Cullen, S, van Heel, D, Orchard, T R, Welsh, K I, Marshall, S E, Jewell, D P
Vydáno 2003

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis

Autor Felice, C., Leccese, P., Scudeller, L., Lubrano, E., Cantini, F., Castiglione, F., Gionchetti, P., Orlando, A., Salvarani, C., Scarpa, R., Vecchi, M., Olivieri, I., Armuzzi, A.
Vydáno v Clin Exp Immunol (2019)

Immune Response to Influenza A/H1N1 Vaccine in Inflammatory Bowel Disease Patients Treated with Anti TNF-α Agents: Effects of Combined Therapy with Immunosuppressants

Autor Andrisani, G., Frasca, D., Romero, M., Armuzzi, A., Felice, C., Marzo, M., Pugliese, D, Papa, A., Mocci, G., De Vitis, I., Rapaccini, G.L., Blomberg, B.B., Guidi, L
Vydáno 2012

P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients’ a...

Autor Costantino, A, Noviello, D, Conforti, F S, Aloi, M, Armuzzi, A, Bossa, F, Ficari, F, Leone, S, Manguso, F, Mocci, G, Orlando, A, Pironi, L, Radice, S, Rizzello, F, Tongiorgi, A, Costantino, C, Vecchi, M, Caprioli, F
Vydáno v J Crohns Colitis (2021)

A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN’S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE

Autor Panaccione, R, Colombel, J, Bossuyt, P, Baert, F, Vanasek, T, Danalioglu, A, Novacek, G, Armuzzi, A, Reinisch, W, Johnson, S, Buessing, M, Neimark, E, Petersson, J, Robinson, A M, Thakkar, R B, Lee, W, Skup, M, D’Haens, G
Vydáno v J Can Assoc Gastroenterol (2019)